The solo play Every Brilliant Thing will launch a North American national tour in 2027 beginning in Seattle.
The announcement was delivered on May 19, 2026, by Mariska Hargitay during the Broadway League Spring Road Conference. Hargitay, who steps into the production later this spring, shared the news as the current Broadway engagement continues to draw audiences at the Hudson Theatre.
The play, written by Duncan Macmillan and Jonny Donahoe, features Daniel Radcliffe in the lead role through the spring. His performance earned a Tony Award nomination, and the production itself is nominated for the 2026 Tony Award for Best Revival of a Play. Multiple extensions have kept the limited run active amid strong ticket demand.
Hargitay begins her limited engagement on May 26, 2026, and performs through July 5. Tracee Ellis Ross assumes the central role starting July 7.
I read 'Every Brilliant Thing' and cried, rejoiced, laughed, cried some more, and loved it so much. It feels like an extraordinary gift to make my Broadway debut, the fulfillment of a lifelong dream, with a play that affirms life so emphatically. — Mariska Hargitay, actress
Hargitay made the statement in connection with her upcoming Broadway debut. Casting, exact performance dates, and additional tour cities beyond the Seattle launch remain to be announced.
Reports from Playbill, TicketNews, and BroadwayNews.com confirm the 2027 tour plans while noting the production's continued momentum on Broadway. The move extends the play's reach to new markets across the continent following its New York success.
